Natural products pave their way in cancer therapy

Cancer Biology and Therapy

Volumn 8, Issue 19, 2009, Pages 1869-1870

  Efferth, Thomas ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Cancer; Chemotherapy; Natural products; Nuclear factor kappaB

Indexed keywords

ALKALOID DERIVATIVE; CAMPTOTHECIN; CISPLATIN; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NATURAL PRODUCT; NUPHAR LUTEA EXTRACT; PACLITAXEL; PLANT EXTRACT; TENIPOSIDE; THIOALKALOID DERIVATIVE; UNCLASSIFIED DRUG; VINCA ALKALOID;

APOPTOSIS; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; MEDICINAL PLANT; NEOPLASM; NOTE; NUPHAR;

BIOLOGICAL PRODUCTS; HUMANS; NEOPLASMS; PLANTS, MEDICINAL;

EID: 73549083829     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.19.9691     Document Type: Note

References (26)

1. Rhoads CP. Report on a cooperative study of nitrogen mustard (HN2) therapy of neoplastic disease. Trans Assoc Am Physicians 1947; 60:110-7.
2. Volm M, Koomägi R, Efferth T. Prediction of drug sensitivity and resistance of cancer by protein expression profiling. Cancer Genomics Proteomics 2004; 1:157-66.
3. Efferth T, Volm M. Pharmacogenetics for individualized cancer chemotherapy. Pharmacol Ther 2005; 107:155-76.
4. Gillet JP, Efferth T, Remacle J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochem Biophys Acta Rev Cancer 2007; 1775:237-62.
5. Efferth T, Konkimalla VB, Wang YF, Sauerbrey A, Meinhardt S, Zintl F, et al. Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin Cancer Res 2008; 14:2405-12.
6. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70:461-77.
7. Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets 2006; 7:407-21.
8. Efferth T. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside. Planta Med 2007; 73:299-309.
9. Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13:353-61.
10. Efferth T, Miyachi H, Bartsch H. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy. Cancer Genomics Proteomics 2007; 4:81-91.
11. Efferth T, Fu YJ, Zu YG, Schwarz G, Konkimalla VS, Wink M. Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Curr Med Chem 2007; 14:2024-32.
12. Efferth T, Kahl S, Paulus K, Adams M, Rauh R, Boechzelt H, et al. Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells. Mol Cancer Ther 2008; 7:152-61.
13. Wink M. Plant breeding: importance of plant secondary metabolites for protection against pathogens and herbivores. Theor Appl Genet 1988; 75:225-33.
14. Efferth T, Miyachi H, Drexler HG, Gebhart E. Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells. Blood Cells Mol Dis 2002; 28:47-56.
15. Efferth T, Gebhart E, Ross DD, Sauerbrey A. Identification of gene expression profiles predicting tumor cell response to L-alanosine. Biochem Pharmacol 2003; 66:613-21.
16. Efferth T, Kaina B. Microarray-based prediction of cytotoxicity of tumor cells to arsenic trioxide, Cancer Genomics Proteomics 2004; 1:363-70.
17. Efferth T, Rauh R, Kahl S, Tomicic M, Böchzelt H, Tome ME, et al. Molecular modes of action of cantharidin in tumor cells. Biochem Pharmacol 2005; 69:811-8.
18. Efferth T, Chen ZP, Kaina B. Molecular determinants of response of tumor cells to berberine, Cancer Genomics Proteomics 2005; 2:115-24.
19. Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 2008; 68:4347-51.
20. Ozer J, Eisner N, Ostrozhenkova E, Bacher A, Eisenreich W, Benharroch D, et al. Nuphar lutea thioalkaloids inhibit the nuclear factor κB pathway, potentiate apoptosis and are synergistic with cisplatin and etoposide. Cancer Biol Ther 2009; 8:1860-8.
21. Fulda S. Tumor resistance to apoptosis. Int J Cancer 2009; 124:511-5.
22. Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2007; 2:693.
23. Yu Y, Wan Y, Huang C. The biological functions of NFkappaB1 (p50) and its potential as an anti-cancer target. Curr Cancer Drug Targets 2009; 9:566-71.
24. Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A. The transcription factor nuclear factor-kappaB and cancer. Clin Oncol 2007; 19:154-61.
25. Yu Y, Wan Y, Huang C. The biological functions of NFkappaB1 (p50) and its potential as an anti-cancer target. Curr Cancer Drug Targets 2009; 9:566-71.
26. Ríos JL, Recio MC, Escandell JM, Andújar I. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Curr Pharm Des 2009; 15:1212-37.